Jpmorgan Chase & CO Insmed Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Insmed Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,354,022 shares of INSM stock, worth $662 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,354,022
Previous 3,286,248
93.35%
Holding current value
$662 Million
Previous $227 Million
113.66%
% of portfolio
0.04%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding INSM
# of Institutions
491Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.9 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.6 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.49 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$1.35 Billion0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$750 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $14.1B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...